Unlocking Cardioprotective Potential of Gut Microbiome: Exploring Therapeutic Strategies

被引:0
作者
Qu, Jun [1 ]
Meng, Fantao [2 ]
Wang, Zhen [1 ]
Xu, Wenhao [1 ]
机构
[1] Yantai Yuhuangding Hosp, Dept Internal Med Cardiovasc, Yantai, Shandong, Peoples R China
[2] Linyi Cent Hosp, Dept Internal Med Cardiovasc, Linyi, Shandong, Peoples R China
关键词
Microbiome dysbiosis; probiotics; prebiotics; synbiotics; TMAO inhibitors; atherosclerosis; INTERNATIONAL SCIENTIFIC ASSOCIATION; TRIMETHYLAMINE-N-OXIDE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CHLAMYDIA-PNEUMONIAE; CONSENSUS STATEMENT; HEART-FAILURE; SUPPLEMENTATION; CONSUMPTION; PROBIOTICS;
D O I
10.4014/jmb.2405.05019
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The microbial community inhabiting the human gut resembles a bustling metropolis, wherein beneficial bacteria play pivotal roles in regulating our bodily functions. These microorganisms adeptly break down resilient dietary fibers to fuel our energy, synthesize essential vitamins crucial for our well-being, and maintain the delicate balance of our immune system. Recent research indicates a potential correlation between alterations in the composition and activities of these gut microbes and the development of coronary artery disease (CAD). Consequently, scientists are delving into the intriguing realm of manipulating these gut inhabitants to potentially mitigate disease risks. Various promising strategies have emerged in this endeavor. Studies have evidenced that probiotics can mitigate inflammation and enhance the endothelial health of our blood vessels. Notably, strains such as Lactobacilli and Bifidobacteria have garnered substantial attention in both laboratory settings and clinical trials. Conversely, prebiotics exhibit anti-inflammatory properties and hold potential in managing conditions like hypertension and hypercholesterolemia. Synbiotics, which synergistically combine probiotics and prebiotics, show promise in regulating glucose metabolism and abnormal lipid profiles. However, uncertainties persist regarding postbiotics, while antibiotics are deemed unsuitable due to their potential adverse effects. On the other hand, TMAO blockers, such as 3,3-dimethyl-1-butanol, demonstrate encouraging outcomes in laboratory experiments owing to their anti-inflammatory and tissue-protective properties. Moreover, fecal transplantation, despite yielding mixed results, warrants further exploration and refinement. In this comprehensive review, we delve into the intricate interplay between the gut microbiota and CAD, shedding light on the multifaceted approaches researchers are employing to leverage this understanding for therapeutic advancements.
引用
收藏
页码:2413 / 2424
页数:12
相关论文
共 139 条
  • [1] Cardioprotective effect of pretreatment with β-glucan in coronary artery bypass grafting
    Aarsaether, Erling
    Rydningen, Mona
    Engstad, Rolf Einar
    Busund, Rolf
    [J]. SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2006, 40 (05) : 298 - 304
  • [2] Lactobacillus plantarum probiotic induces Nrf2-mediated antioxidant signaling and eNOS expression resulting in improvement of myocardial diastolic function
    Aboulgheit, Ahmed
    Karbasiafshar, Catherine
    Zhang, Zhiqi
    Sabra, Mohamed
    Shi, Guangbin
    Tucker, Aja
    Sodha, Neel
    Abid, M. Ruhul
    Sellke, Frank W.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2021, 321 (05): : H839 - H849
  • [3] Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials
    Arabi, Seyyed Mostafa
    Bahrami, Leila Sadat
    Rahnama, Iman
    Sahebkar, Amirhossein
    [J]. PHARMACOLOGICAL RESEARCH, 2022, 176
  • [4] The Effects of the Mediterranean Diet on Health and Gut Microbiota
    Barber, Thomas M.
    Kabisch, Stefan
    Pfeiffer, Andreas F. H.
    Weickert, Martin O.
    [J]. NUTRIENTS, 2023, 15 (09)
  • [5] Trimethylamine N-oxide, Mediterranean diet, and nutrition in healthy, normal-weight adults: also a matter of sex?
    Barrea, Luigi
    Annunziata, Giuseppe
    Muscogiuri, Giovanna
    Laudisio, Daniela
    Di Somma, Carolina
    Maisto, Maria
    Tenore, Gian Carlo
    Colao, Annamaria
    Savastano, Silvia
    [J]. NUTRITION, 2019, 62 : 7 - 17
  • [6] A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis
    Brandsma, Eelke
    Kloosterhuis, Niels J.
    Koster, Mirjam
    Dekker, Daphne C.
    Gijbels, Marion J. J.
    van der Velden, Saskia
    Rios-Morales, Melany
    van Faassen, Martijn J. R.
    Loreti, Marco G.
    de Bruin, Alain
    Fu, Jingyuan
    Kuipers, Folkert
    Bakker, Barbara M.
    Westerterp, Marit
    de Winther, Menno P. J.
    Hofker, Marten H.
    van de Sluis, Bart
    Koonen, Debby P. Y.
    [J]. CIRCULATION RESEARCH, 2019, 124 (01) : 94 - 100
  • [7] Trimethylamine-N-Oxide Promotes Age-Related Vascular Oxidative Stress and Endothelial Dysfunction in Mice and Healthy Humans
    Brunt, Vienna E.
    Gioscia-Ryan, Rachel A.
    Casso, Abigail G.
    VanDongen, Nicholas S.
    Ziemba, Brian P.
    Sapinsley, Zachary J.
    Richey, James J.
    Zigler, Melanie C.
    Neilson, Andrew P.
    Davy, Kevin P.
    Seals, Douglas R.
    [J]. HYPERTENSION, 2020, 76 (01) : 101 - 112
  • [8] Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
    Byndloss, Mariana X.
    Olsan, Erin E.
    Rivera-Chavez, Fabian
    Tiffany, Connor R.
    Cevallos, Stephanie A.
    Lokken, Kristen L.
    Torres, Teresa P.
    Byndloss, Austin J.
    Faber, Franziska
    Gao, Yandong
    Litvak, Yael
    Lopez, Christopher A.
    Xu, Gege
    Napoli, Eleonora
    Giulivi, Cecilia
    Tsolis, Renee M.
    Revzin, Alexander
    Lebrilla, Carlito B.
    Baumler, Andreas J.
    [J]. SCIENCE, 2017, 357 (6351) : 570 - +
  • [9] Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals
    Canfora, Emanuel E.
    van der Beek, Christina M.
    Hermes, Gerben D. A.
    Goossens, Gijs H.
    Jocken, Johan W. E.
    Holst, Jens J.
    van Eijk, Hans M.
    Venema, Koen
    Smidt, Hauke
    Zoetendal, Erwin G.
    Dejong, Cornelis H. C.
    Lenaerts, Kaatje
    Blaak, Ellen E.
    [J]. GASTROENTEROLOGY, 2017, 153 (01) : 87 - +
  • [10] Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome
    Cannon, CP
    Braunwald, E
    McCabe, CH
    Grayston, JT
    Muhlestein, B
    Giugliano, RP
    Cairns, R
    Skene, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) : 1646 - 1654